Copeptin was shown to provide additional information to troponin in the triage of chest pain patients and to improve the diagnostic performance of NT-proBNP in predicting risk of all-cause mortality in patients with chronic heart failure [22,28]. The gene discussed is AVP; the disease is congestive heart failure.